Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab-Reference-Cited by-同舟云学术

Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab

Published:2024-08-13 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Grolleau Chloé¹²^ORCID,Poisot Thomas²,Hadjadj Jérôme³,Jachiet Marie¹^ORCID,Mahevas Thibault¹^ORCID,Le Buanec Hélène²,Bouaziz Jean‐David¹²^ORCID,Chasset François⁴

Affiliation:

1. Dermatology Department Saint Louis Hospital Paris France

2. Saint‐Louis Research Institute, INSERM U976 – HIPI Unit University of Paris Paris France

3. Service de Médecine Interne et Inflammation‐Immunopathology‐Biotherapy Department (DMU i3) Sorbonne Université, Assistance Publique‐Hôpitaux de Paris, Centre Hospitalo‐Universitaire Saint‐Antoine Paris France

4. Service de Dermatologie et Allergologie, Faculté de médecine Sorbonne Université, Hôpital Tenon, Assistance Publique‐Hôpitaux de Paris Paris France

Funder

Société Française de Dermatologie et de Pathologie Sexuellement Transmissible

Pfizer

AstraZeneca France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20283

Reference9 articles.

1. Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches;Wenzel J;Exp Dermatol,2007

2. Interferon‐inducible gene expression signature in peripheral blood cells of patients with severe lupus;Baechler EC;Proc Natl Acad Sci U S A,2003

3. Trial of Anifrolumab in Active Systemic Lupus Erythematosus

4. Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus;Chasset F;J Am Acad Dermatol,2023

5. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal‐derived interferon kappa;Sarkar MK;Ann Rheum Dis,2018